DINO MANGION
PhD-qualified chemist and pharmaceutical industry leader with 21 years’ experience across generic drug substance (API/DS) development, scale-up and GMP manufacture, and senior site leadership within vertically integrated operations (API + solid oral finished dosage forms). Proven track record scaling portfolios and output, leading multi-disciplinary teams, and delivering sustained EU GMP compliance and global market access (including US FDA and ANVISA accreditations). Strong R&D and CMC foundations (lab-to-plant) with publications and patents; adept at bridging R&D, manufacturing, QC/QA, engineering and supply to deliver robust processes and reliable supply.
Pharmaceutical R&D company that identifies promising future generic API opportunities early, de-risks their development through specialist external partners, and converts them into technology-transfer-ready packages for API manufacturers.
Members can reach out privately. Say what you need in one line — that's the house style.
JOIN TO UNLOCK — FREE